JPRN-UMIN000022606已完成未知
Clinical usefulness of serum Mac-2 binding protein glycosylation isomer (M2BPGi) as a novel biomarker in respiratory diseases - Serum M2BPGi in respiratory diseases
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who are unable to get informed consent
研究者
相似试验
已完成
不适用
Clinical usefulness of serum Mac-2 binding protein glycosylation isomer in decompensated cirrhosisliver cirrhosisJPRN-UMIN000030234Kitasato University School of Medicine500
已完成
不适用
sefulness of serum Mac-2 binding protein glycosylation isomer in patients undergoing hepatectomyThe patients with liver diseases who were undergoing hepatic resectionsJPRN-UMIN000036699niversity of Miyazaki, Faculty of Medicine115
已完成
不适用
The usefulness of serum APM2 as a predictable marker for the response to platinum based antineoplastic drugs.Hepatocellular carcinoma, Gastric cancer, Esophageal cancerJPRN-UMIN000028487Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University100
已完成
2 期
Phase IIb study on the safety and efficacy of BM32, a recombinant hypoallergenic vaccine for immunotherapy of grass pollen allergygrass pollen allergy10001708NL-OMON39223Biomay AG20
招募中
不适用
The use of novel protein biomarkers in predicting clinical outcomes in patients with localised and metastatic colorectal cancerColorectal cancerACTRN12610000776000Cancer Institute NSW200